The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
- PMID: 2175676
- DOI: 10.1016/0092-8674(90)90409-8
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Abstract
The E6 protein encoded by the oncogenic human papillomavirus types 16 and 18 is one of two viral products expressed in HPV-associated cancers. E6 is an oncoprotein which cooperates with E7 to immortalize primary human keratinocytes. Insight into the mechanism by which E6 functions in oncogenesis is provided by the observation that the E6 protein encoded by HPV-16 and HPV-18 can complex the wild-type p53 protein in vitro. Wild-type p53 gene has tumor suppressor properties, and is a target for several of the oncoproteins encoded by DNA tumor viruses. In this study we demonstrate that the E6 proteins of the oncogenic HPVs that bind p53 stimulate the degradation of p53. The E6-promoted degradation of p53 is ATP dependent and involves the ubiquitin-dependent protease system. Selective degradation of cellular proteins such as p53 with negative regulatory functions provides a novel mechanism of action for dominant-acting oncoproteins.
Similar articles
-
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review.
-
Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.J Virol. 1992 Aug;66(8):5100-5. doi: 10.1128/JVI.66.8.5100-5105.1992. J Virol. 1992. PMID: 1321290 Free PMC article.
-
Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.Virology. 2002 Jul 20;299(1):72-87. doi: 10.1006/viro.2002.1502. Virology. 2002. PMID: 12167343
-
Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.J Virol. 2000 Jul;74(14):6408-17. doi: 10.1128/jvi.74.14.6408-6417.2000. J Virol. 2000. PMID: 10864652 Free PMC article.
-
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.Cancer Surv. 1992;12:197-217. Cancer Surv. 1992. PMID: 1322242 Review.
Cited by
-
Mechanisms and regulation of substrate degradation by the 26S proteasome.Nat Rev Mol Cell Biol. 2024 Oct 3. doi: 10.1038/s41580-024-00778-0. Online ahead of print. Nat Rev Mol Cell Biol. 2024. PMID: 39362999 Review.
-
Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta‑analysis.Oncol Lett. 2024 Sep 19;28(6):556. doi: 10.3892/ol.2024.14689. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39355783 Free PMC article.
-
Exploring the Multifactorial Landscape of Penile Cancer: A Comprehensive Analysis of Risk Factors.Diagnostics (Basel). 2024 Aug 16;14(16):1790. doi: 10.3390/diagnostics14161790. Diagnostics (Basel). 2024. PMID: 39202278 Free PMC article. Review.
-
Pyrimidine Triones as Potential Activators of p53 Mutants.Biomolecules. 2024 Aug 8;14(8):967. doi: 10.3390/biom14080967. Biomolecules. 2024. PMID: 39199355 Free PMC article.
-
GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner.Cell Death Discov. 2024 Aug 29;10(1):385. doi: 10.1038/s41420-024-02143-8. Cell Death Discov. 2024. PMID: 39198399 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous